- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies
Journal of Medical Ethics 43 (6):391-400 (2017)
Abstract
This article has no associated abstract. (fix it)Author's Profile
Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Sign in / register and customize your OpenURL resolver
- Configure custom resolver
My notes
Similar books and articles
Clinical Trials and Scid Row: The Ethics of Phase 1 Trials in the Developing World.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128-135.
Clinical trials and scid row: The ethics of phase 1 trials in the developing world.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128–135.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
The physician's role in the protection of human research subjects.Professor John R. Williams - 2006 - Science and Engineering Ethics 12 (1):5-12.
Informed consent in emergency research: A contradiction in terms.Malcolm G. Booth - 2007 - Science and Engineering Ethics 13 (3):351-359.
‘Risky’ research and participants' interests: the ethics of phase 2C clinical trials.Sarah Chan, Ying-Kiat Zee, Gordon Jayson & John Harris - 2011 - Clinical Ethics 6 (2):91-96.
Selecting the Right Tool For the Job.Arthur L. Caplan, Carolyn Plunkett & Bruce Levin - 2015 - American Journal of Bioethics 15 (4):4-10.
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16-.
Regulating trust in pediatric clinical trials.Wim Pinxten, Herman Nys & Kris Dierickx - 2008 - Medicine, Health Care and Philosophy 11 (4):439-444.
The Duty to Exclude: Excluding People at Undue Risk from Research.Charles Weijer & Abraham Fuks - unknown
The physician’s role in the protection of human research subjects.John R. Williams - 2006 - Science and Engineering Ethics 12 (1):5-12.
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Analytics
Added to PP
2017-05-27
Downloads
24 (#642,030)
6 months
11 (#225,837)
2017-05-27
Downloads
24 (#642,030)
6 months
11 (#225,837)
Historical graph of downloads
Author's Profile
Citations of this work
Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility.Nancy S. Jecker, Aaron G. Wightman, Abby R. Rosenberg & Douglas S. Diekema - 2018 - American Journal of Bioethics 18 (4):58-67.
Perverse Effects: How Insufficient Guidance to IPFs Can Undermine Both Research and Health Outcomes of Clinical Trials.John W. Frye - 2018 - American Journal of Bioethics 18 (4):78-80.
Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.Nancy S. Jecker - 2017 - American Journal of Bioethics 17 (10):70-71.
Context is Needed When Assessing Fair Subject Selection.G. Owen Schaefer - 2020 - American Journal of Bioethics 20 (2):20-22.
The Challenge of Selecting Participants Fairly in High-Demand Clinical Trials.Annette Rid, Saskia Hendriks & Alexander A. Iyer - 2020 - American Journal of Bioethics 20 (2):35-38.
References found in this work
Principles for allocation of scarce medical interventions.Govind Persad, Alan Wertheimer & Ezekiel J. Emanuel - 2009 - The Lancet 373 (9661):423--431.
Morality, Mortality, Vol. 1: Death and Whom to Save from It.Frances Kamm - 1998 - Philosophical and Phenomenological Research 58 (4):963-967.
The Problem with Rescue Medicine.N. S. Jecker - 2013 - Journal of Medicine and Philosophy 38 (1):64-81.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-hc2g5 uwo